Post-treatment with oxcarbazepine confers potent neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway - 11/02/20
pages | 12 |
Iconographies | 7 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | OXC post-treatment in transient ischemia protects neurons in hippocampal CA1. |
• | OXC attenuates ischemia-induced oxidative stress in ischemic CA1. |
• | OXC suppresses ischemia-induced neuroinflammation in ischemic CA1. |
• | OXC increases expressions of Nrf2 and its downstream protein HO-1 in ischemic CA1. |
• | A Nrf2 inhibitor abolishes protective effects of OXC against ischemic injury. |
Abstract |
Oxcarbazepine (OXC), a voltage-gated sodium channel blocker, is an antiepileptic medication and used for the bipolar disorders treatment. Some voltage-gated sodium channel blockers have been demonstrated to display strong neuroprotective properties in models of cerebral ischemia. However, neuroprotective effects and mechanisms of OXC have not yet been reported. Here, we investigated the protective effect of OXC and its mechanisms in the cornu ammonis 1 subfield (CA1) of gerbils subjected to 5 min of transient global cerebral ischemia (tGCI). tGCI led to death of most pyramidal neurons in CA1 at 5 days after ischemia. OXC (100 and 200 mg/kg) was intraperitoneally administered once at 30 min after tGCI. Treatment with 200 mg/kg, not 100 mg/kg OXC, significantly protected CA1 pyramidal neurons from tGCI-induced injury. OXC treatment significantly decreased superoxide anion production, 4-hydroxy-2-nonenal and 8-hydroxyguanine levels in ischemic CA1 pyramidal neurons. In addition, the treatment restored levels of superoxide dismutases, catalase, and glutathione peroxidase. Furthermore, the treatment distinctly inhibited tGCI-induced microglia activation and significantly reduced levels of pro-inflammatory cytokines (interleukin-1β and tumor necrosis factor-α). In particular, OXC treatment significantly enhanced expressions of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream protein heme oxygenase-1 in ischemic CA1. The neuroprotective effects of OXC were abolished by brusatol (an inhibitor of Nrf2). Taken together, these results indicate that post-treatment of OXC can display neuroprotection against brain injuries following ischemic insults. This neuroprotection may be displayed by attenuation of oxidative stress and neuroinflammation, which can be mediated by activation of Nrf2 pathway.
Le texte complet de cet article est disponible en PDF.Abbreviations : 4-HNE, 8-OHG, BR, CA1, CAT, CNS, CV, DHE, F-J B, GPX, HO-1, Iba-1, IL, Nrf2, OXC, PAT, ROS, SMA, SOD, tGCI, TNF, VGSC
Keywords : Nuclear factor erythroid 2-related factor 2, Neuroinflammation, Neuronal death, Oxcarbazepine, Oxidative stress, Transient global cerebral ischemia
Plan
Vol 124
Article 109850- avril 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?